CID 515825
N1-((1s,2s,4s)-1-benzyl-2-hydroxy-5-phenyl-4-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}pentyl)-n2-({cyclopropyl[(2-isopropyl-1,3-thiazol-4-yl)methyl]amino}carbonyl)-l-valinamide
Structural Information
- Molecular Formula
- C39H50N6O5S2
- SMILES
- CC(C)C1=NC(=CS1)CN(C2CC2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC3=CC=CC=C3)[C@H](C[C@H](CC4=CC=CC=C4)NC(=O)OCC5=CN=CS5)O
- InChI
- InChI=1S/C39H50N6O5S2/c1-25(2)35(44-38(48)45(31-15-16-31)21-30-23-51-37(41-30)26(3)4)36(47)43-33(18-28-13-9-6-10-14-28)34(46)19-29(17-27-11-7-5-8-12-27)42-39(49)50-22-32-20-40-24-52-32/h5-14,20,23-26,29,31,33-35,46H,15-19,21-22H2,1-4H3,(H,42,49)(H,43,47)(H,44,48)/t29-,33-,34-,35-/m0/s1
- InChIKey
- QMVLHLXYEJEQJU-HNJBERQJSA-N
- Compound name
- 1,3-thiazol-5-ylmethyl N-[(2S,4S,5S)-5-[[(2S)-2-[[cyclopropyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-3-methylbutanoyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]carbamate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 747.33568 | 242.1 |
[M+Na]+ | 769.31762 | 236.4 |
[M-H]- | 745.32112 | 252.4 |
[M+NH4]+ | 764.36222 | 234.2 |
[M+K]+ | 785.29156 | 233.9 |
[M+H-H2O]+ | 729.32566 | 235.7 |
[M+HCOO]- | 791.32660 | 249.0 |
[M+CH3COO]- | 805.34225 | 286.1 |
[M+Na-2H]- | 767.30307 | 237.7 |
[M]+ | 746.32785 | 250.0 |
[M]- | 746.32895 | 250.0 |
Literature stripe
Patent stripe
No patent data available for this compound.